Questionable efficacy for naltrexone in patients with Asp40.
Mattes
Jeffrey A
JA
D000437:Alcoholism / Q000235:genetics* / Q000534:rehabilitation*; D000483:Alleles; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D004843:Epistasis, Genetic / Q000235:genetics; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D017450:Receptors, Opioid, mu / Q000235:genetics*; D016896:Treatment Outcome
D009292:Narcotic Antagonists; C485764:OPRM1 protein, human; D017450:Receptors, Opioid, mu; D009271:Naltrexone